Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a/2b

Melanie Deutsch Academic Department of Internal Medicine, Hippokration General Hospital, Athens, GreeceCorrespondence[email protected]

, MD,

Emanuel K. Manesis Academic Department of Internal Medicine, Hippokration General Hospital, Athens, Greece

Emilia Hadziyannis Academic Department of Internal Medicine, Hippokration General Hospital, Athens, Greece

Dimitrios Vassilopoulos Academic Department of Internal Medicine, Hippokration General Hospital, Athens, Greece

Athanasios J. Archimandritis Academic Department of Internal Medicine, Hippokration General Hospital, Athens, Greece

References

Wilson LE, Widman D, Dikman SH, Gorevic PD. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin Arthritis Rheum 2002; 32: 163–73
PubMed Web of Science ®Google Scholar
Ramos-Casals M, Garcia-Carrasco M, Lopez-Medrano F, Trejo O, Forns X, Lopez-Guillermo A, et al. Severe autoimmune cytopenias in treatment naïve hepatitis C virus infection: clinical description of 35 cases. Medicine (Baltimore) 2003; 82: 87–96
PubMed Web of Science ®Google Scholar
Iyoda K, Kato M, Nakagawa T, Kakiuchi Y, Sugiyasu Y, Fujii E, et al. Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatitis C. J Gastroenterol 1998; 33: 588–92
PubMedGoogle Scholar
Yagita M, Uemura M, Nakamura T, Kunitomi A, Matsumoto M, Fujimura Y. Development of ADAMTS13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpura. J Hepatol 2005; 42: 420–1
PubMed Web of Science ®Google Scholar
Stribling JY, Ahmed K, Waller A, Ahmed U, Shade RR. Thrombotic thrombocytopenic purpura (TTP) associated with interferon therapy of hepatitis C [abstract]. Am J Gastroenterol 2004; 99 Suppl 10: 295
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a/2b

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a/2b

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date